frost sullivan logoCollaboration with customers is at the heart of the innovation process for Mach7 Technologies. Working closely with partners and customers across the spectrum of Healthcare providers, the company is able to leverage its focused development resources to sense and respond rapidly to emerging market needs and adjust swiftly to varying market conditions.

– Frost & Sullivan

fresenius logoMach7 products enable us to manage our imaging data and provide the necessary clinical access to enhance patient care. Ther application installed without issue and integrated very easily and seamlessly with our existing modalities and upstream systems. We are very pleased with our decision to work with Mach7 Technologies.

– Ernie Gutierrez, Director of Operations for U.S. Vascular

HCA International logoWorking with Mach7 Technologies has been a dream. We were on a tight timeline with this project, and needed a solution to be up and running in just a few months. Mach7’s Professional Services team was very comprehensive on what was needed to make the installation a success. Overall, this was a spec­tacular way to showcase the technology, and we know we’re not utilizing it to the fullest extent yet.

– Kaye Bonython, Head of Imaging Informatics at HCA International

University of Virginia Health System logoOne of the great advantages of Mach7 Enterprise Imaging Platform is that the archives really lay out the images and the data in a simple way so that you avoid that vendor lock-in, and you can really take control of your data.

– Daniel O’Malley, Director of Informatics and Support Services at the University of Virginia Health System

Singapore General Hospital logoWe believe that we selected the best solution for the Department. After evaluating several different solutions, only Mach7 Enterprise Image Management Platform met all of the series-level routing and PACS-neutral archive requirements that we had. Based on our preliminary benchmarks, we expect Mach7 to improve NM technologist productivity significantly.

– Dr. Anthony Goh, Head of SGH’s Nuclear Medicine and PET